PMVP PMV Pharmaceuticals Inc

Price (delayed)

$1.19

Market cap

$63.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.49

Enterprise value

$24.63M

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 26
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. ...

Highlights
The debt has dropped by 74% year-on-year and by 65% since the previous quarter
The quick ratio is down by 34% YoY but it is up by 10% QoQ
PMVP's equity is down by 45% year-on-year and by 16% since the previous quarter
The company's net income fell by 29% YoY

Key stats

What are the main financial stats of PMVP

PMVP stock price

How has the PMV Pharmaceuticals stock price performed over time
Intraday
2.59%
1 week
0%
1 month
-15%
1 year
27.96%
YTD
-4.8%
QTD
-4.03%

Financial performance

How have PMV Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$83.66M
Net income
-$78.34M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 29% YoY
PMVP's operating income is up by 6% YoY and by 3% from the previous quarter

Price vs fundamentals

How does PMVP's price correlate with its fundamentals

Growth

What is PMV Pharmaceuticals's growth rate over time

Valuation

What is PMV Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.72
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 26% year-on-year
PMVP's price to book (P/B) is 53% less than its 5-year quarterly average of 1.5 but 17% more than its last 4 quarters average of 0.6
PMVP's equity is down by 45% year-on-year and by 16% since the previous quarter

Efficiency

How efficient is PMV Pharmaceuticals business performance
The company's return on equity has shrunk by 112% YoY and by 17% QoQ
The return on assets has dropped by 112% year-on-year and by 16% since the previous quarter
PMV Pharmaceuticals's ROIC has plunged by 101% YoY and by 18% from the previous quarter

Dividends

What is PMVP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PMVP.

Financial health

How did PMV Pharmaceuticals financials performed over time
The total assets has declined by 43% year-on-year and by 17% since the previous quarter
The quick ratio is down by 34% YoY but it is up by 10% QoQ
The debt is 100% smaller than the equity
The company's debt to equity has shrunk by 100% QoQ and by 100% YoY
The debt has dropped by 74% year-on-year and by 65% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.